Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
7,354,969
-
Total 13F shares
-
9,337,563
-
Share change
-
+283,848
-
Total reported value
-
$220,365,047
-
Price per share
-
$23.60
-
Number of holders
-
40
-
Value change
-
+$7,169,032
-
Number of buys
-
24
-
Number of sells
-
16
Institutional Holders of Kezar Life Sciences, Inc. - Common Stock, $0.001 par value (KZR) as of Q4 2018
As of 31 Dec 2018,
Kezar Life Sciences, Inc. - Common Stock, $0.001 par value (KZR) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,337,563 shares.
The largest 10 holders included
FMR LLC, Cormorant Asset Management, LP, EcoR1 Capital, LLC, COWEN INC., BB BIOTECH AG, Omega Fund Management, LLC, FRANKLIN RESOURCES INC, FRAZIER MANAGEMENT LLC, BlackRock Inc., and VICTORY CAPITAL MANAGEMENT INC.
This page lists
40
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.